Exact Mass: 329.191

Exact Mass Matches: 329.191

Found 500 metabolites which its exact mass value is equals to given mass value 329.191, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sinomenine

(1R,9S,10R)-3-Hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one

C19H23NO4 (329.1627)


Sinomenine is a morphinane alkaloid. Sinomenine is a natural product found in Sinomenium acutum, Stephania cephalantha, and other organisms with data available. Sinomenine is an alkaloid isolated from the root of Sinomenium acutum with immunomodulatory and potential anti-angiogenic and activities. Although the mechanism of action remains to be fully elucidated, sinomenine appears to inhibit endothelial proliferation mediated through basic fibroblast growth factor (bFGF), which may contribute to its anti-angiogenic effect. In Chinese medicine, this agent has a long track-record in treating arthritis, which is accounted by its ability to inhibit proliferation of synovial fibroblasts and lymphocytes. In addition, sinomenine has been shown to suppress expressions of genes involved in inflammation and apoptosis, such as interleukin-6, a pleiotropic inflammatory cytokine and JAK3 (Janus kinase 3), Daxx (death-associated protein 6), plus HSP27 (heat shock 27kDa protein 1), respectively. D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D018501 - Antirheumatic Agents Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.366 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.360 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.362 Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   

(S)-Reticuline

7-ISOQUINOLINOL, 1,2,3,4-TETRAHYDRO-1-((3-HYDROXY-4-METHOXYPHENYL)METHYL)-6-METHOXY-2-METHYL-, (1S)-

C19H23NO4 (329.1627)


(S)-Reticuline is an endogenous precursor of morphine (PMID: 15383669). (S)-Reticuline is a key intermediate in the synthesis of morphine, the major active metabolite of the opium poppy. "Endogenous morphine" has been long isolated and authenticated by mass spectrometry in trace amounts from animal- and human-specific tissue or fluids (PMID: 15874902). Human neuroblastoma cells (SH-SY5Y) were shown capable of synthesizing morphine as well. (S)-Reticuline undergoes a change of configuration at C-1 during its transformation into salutaridinol and thebaine. From thebaine, there is a bifurcate pathway leading to morphine proceeding via codeine or oripavine, in both plants and mammals (PMID 15937106). (S)-reticuline is the (S)-enantiomer of reticuline. It has a role as an EC 2.1.1.116 [3-hydroxy-N-methyl-(S)-coclaurine 4-O-methyltransferase] inhibitor. It is a conjugate base of a (S)-reticulinium(1+). It is an enantiomer of a (R)-reticuline. Reticuline is a natural product found in Fumaria capreolata, Berberis integerrima, and other organisms with data available. See also: Peumus boldus leaf (part of). Alkaloid from Papaver somniferum (opium poppy) and Annona reticulata (custard apple) The (S)-enantiomer of reticuline.

   

Trilostane

(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-4-ene-4-carbonitrile

C20H27NO3 (329.1991)


Trilostane is only found in individuals that have used or taken this drug. It is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushings syndrome. It was withdrawn from the United States market in April 1994. [Wikipedia]Trilostane produces suppression of the adrenal cortex by inhibiting enzymatic conversion of steroids by 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase, thus blocking synthesis of adrenal steroids. H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02C - Antiadrenal preparations > H02CA - Anticorticosteroids C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor > C2184 - 3-Hydroxysteroid Dehydrogenase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors Same as: D01180

   

Splendor

Tralkoxydim

C20H27NO3 (329.1991)


   

HETISINE

Hetisan-2,11,13-triol

C20H27NO3 (329.1991)


Annotation level-1

   

EUROPINE

9-Lasiocarpylheliotridine

C16H27NO6 (329.1838)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2321

   

Salutaridinol

5,6,8,14-Tetradehydro-3,6-dimethoxy-17-methyl-morphinan-4,7-diol

C19H23NO4 (329.1627)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

Valclavam

2-[(2-amino-3-methylbutanoyl)amino]-3-hydroxy-4-[(3S,5S)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

C14H23N3O6 (329.1587)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Cinnamoylcocaine

methyl (3S,4R)-8-methyl-3-[(E)-3-phenylprop-2-enoyl]oxy-8-azabicyclo[3.2.1]octane-4-carboxylate

C19H23NO4 (329.1627)


   

Isosinomenine

4-Hydroxy-3,6-dimethoxy-17-methyl-5,6-didehydromorphinan-7-one #

C19H23NO4 (329.1627)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

Trifenmorph

4-Tritylmorpholine

C23H23NO (329.178)


   

(S)-Nor Laudanine

(S)-Nor Laudanine

C19H23NO4 (329.1627)


   

(R)-Reticuline

(1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6- methoxy-2-methyl-7-isoquinolinol

C19H23NO4 (329.1627)


   

Pipertipine

(7E)-8-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)oct-7-en-1-one

C20H27NO3 (329.1991)


Pipertipine is found in herbs and spices. Pipertipine is an alkaloid from the dried seeds of pepper Piper nigrum. Alkaloid from the dried seeds of pepper Piper nigrum. Pipertipine is found in herbs and spices.

   

(8E)-Piperamide-C9:1

(8Z)-9-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one

C20H27NO3 (329.1991)


(8E)-Piperamide-C9:1 is found in herbs and spices. (8E)-Piperamide-C9:1 is a constituent of pepper (Piper nigrum). Constituent of pepper (Piper nigrum). (8E)-Piperamide-C9:1 is found in herbs and spices.

   

Retrofractamide C

(2E,8E)-9-(2H-1,3-Benzodioxol-5-yl)-N-(2-methylpropyl)nona-2,8-dienimidate

C20H27NO3 (329.1991)


Retrofractamide C is an alkaloid from Piper retrofractum (Javanese long pepper). Alkaloid from Piper retrofractum (Javanese long pepper).

   

xi-Anomuricine

6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C19H23NO4 (329.1627)


xi-Anomuricine is found in fruits. Minor alkaloid from the root and stem barks of Annona muricata (soursop). Minor alkaloid from the root and stem barks of Annona muricata (soursop). xi-Anomuricine is found in fruits.

   

6-Keto-decanoylcarnitine

3-[(6-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


6-Keto-decanoylcarnitine is an acylcarnitine. More specifically, it is an 6-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Keto-decanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-keto-decanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

N-desethyloxybutynin

4-(ethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate

C20H27NO3 (329.1991)


N-desethyloxybutynin is a metabolite of oxybutynin. Oxybutynin (Ditropan, Lyrinel XL) is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination, by decreasing muscle spasms of the bladder. It competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic, but at concentrations far above those used clinically. (Wikipedia) D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids

   

Hydroxyethylpromethazine

(2-hydroxyethyl)dimethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]azanium

C19H25N2OS+ (329.1688)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives Hydroxyethylpromethazine is a first-generation phenothiazine H1-antihistamine.

   

5-Hydroxydec-3-enoylcarnitine

3-[(5-hydroxydec-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-3-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydec-8-enoylcarnitine

3-[(5-hydroxydec-8-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-8-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-8-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-8-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-8-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydec-5-enoylcarnitine

3-[(5-hydroxydec-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-5-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-5-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-5-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydec-6-enoylcarnitine

3-[(5-hydroxydec-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-6-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-6-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-6-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-6-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydec-7-enoylcarnitine

3-[(5-hydroxydec-7-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-7-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-7-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-7-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-7-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydec-4-enoylcarnitine

3-[(5-hydroxydec-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Hydroxydec-4-enoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydec-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydec-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydec-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z)-5-Hydroxydec-2-enoylcarnitine

3-[(5-hydroxydec-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


(2Z)-5-Hydroxydec-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2Z)-5-hydroxydec-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z)-5-Hydroxydec-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z)-5-Hydroxydec-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-oxodecanoylcarnitine

3-[(3-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


3-oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 3-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Oxodecanoylcarnitine

3-[(9-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


9-Oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 9-Oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Oxodecanoylcarnitine

3-[(7-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


7-Oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Oxodecanoylcarnitine

3-[(5-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


5-Oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Oxodecanoylcarnitine

3-[(4-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


4-Oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 4-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Oxodecanoylcarnitine

3-[(8-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


8-Oxodecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-oxodecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Oxodecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Oxodecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-5-enedioylcarnitine

3-[(8-carboxyoct-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


Non-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an non-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-5-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-5-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Non-6-enedioylcarnitine

3-[(8-carboxyoct-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


Non-6-enedioylcarnitine is an acylcarnitine. More specifically, it is an non-6-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. non-6-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine non-6-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Non-2-enedioylcarnitine

3-[(8-carboxyoct-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C16H27NO6 (329.1838)


(2E)-non-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-non-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-non-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-non-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Lauroyl Glutamic acid

2-dodecanamidopentanedioic acid

C17H31NO5 (329.2202)


N-lauroyl glutamic acid, also known as N-lauroyl glutamate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Glutamic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Glutamic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Glutamic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

14-Methoxymetopon

10-hydroxy-17-methoxy-4,13-dimethyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one

C19H23NO4 (329.1627)


   

Dapivirine

4-({4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile

C20H19N5 (329.164)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole

6-(4,5-Dihydro-1H-imidazol-2-yl)-2-(4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)-1H-indole

C20H19N5 (329.164)


   

Gabapentin enacarbil

2-(1-{[({1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl)amino]methyl}cyclohexyl)acetic acid

C16H27NO6 (329.1838)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Modrastane

5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile

C20H27NO3 (329.1991)


   

Modrefen

15-hydroxy-2,16-dimethyl-5-oxo-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadecane-4-carbonitrile

C20H27NO3 (329.1991)


   

Oxycodone cr

17-hydroxy-10-methoxy-4-(methylamino)-12-oxapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one

C19H23NO4 (329.1627)


   

Prenylamine

(3,3-diphenylpropyl)(1-phenylpropan-2-yl)amine

C24H27N (329.2143)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

Sinomenine

3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C19H23NO4 (329.1627)


   

Sunepitron

1-[(2-Pyrimidin-2-yl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-7-yl)methyl]pyrrolidine-2,5-dione

C17H23N5O2 (329.1852)


   

1-[(3-Phenyl-3-cyclohexenyl)methyl]-4-phenyl-1,2,3,6-tetrahydropyridine

4-phenyl-1-[(3-phenylcyclohex-3-en-1-yl)methyl]-1,2,3,6-tetrahydropyridine

C24H27N (329.2143)


   

8-trans-Piperamide-C-9-1

(8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one

C20H27NO3 (329.1991)


8-trans-piperamide-c-9-1 is a member of the class of compounds known as benzodioxoles. Benzodioxoles are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms. 8-trans-piperamide-c-9-1 is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 8-trans-piperamide-c-9-1 can be found in pepper (spice), which makes 8-trans-piperamide-c-9-1 a potential biomarker for the consumption of this food product.

   

salutaridinol

4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,10,13-pentaene-3,12-diol

C19H23NO4 (329.1627)


Salutaridinol belongs to phenanthrenes and derivatives class of compounds. Those are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. Salutaridinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Salutaridinol can be found in a number of food items such as pummelo, cardamom, yellow wax bean, and chinese bayberry, which makes salutaridinol a potential biomarker for the consumption of these food products. Salutaridinol is a modified benzyltetrahydroisoquinoline alkaloid with the formula C19H23NO4. It is produced in the secondary metabolism of the opium poppy Papaver somniferum (Papaveraceae) as an intermediate in the biosynthetic pathway that generates morphine. As an isoquinoline alkaloid, it is fundamentally derived from tyrosine as part of the shikimate pathway of secondary metabolism. Salutaridinol is a product of the enzyme salutaridine: NADPH 7-oxidoreductase and the substrate for the enzyme salutaridinol 7-O-acetyltransferase, which are two of the four enzymes in the morphine biosynthesis pathway that generates morphine from (R)-reticuline. Salutaridinols unique position adjacent to two of the four enzymes in the morphine biosynthesis pathway gives it an important role in enzymatic, genetic, and synthetic biology studies of morphine biosynthesis. Salutaridinol levels are indicative of the flux through the morphine biosynthesis pathway and the efficacy of both salutaridine: NADPH 7-oxidoreductase and salutaridinol 7-O-acetyltransferase .

   

Ile-Val-Val

2-({2-[(2-amino-1-hydroxy-3-methylpentylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-methylbutanoic acid

C16H31N3O4 (329.2314)


   

Heliotrine N-oxide

Heliotrine N-oxide

C16H27NO6 (329.1838)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2274

   

Tricalysiamide A

Tricalysiamide A

C20H27NO3 (329.1991)


   
   

Erythrozeylanine C

Erythrozeylanine C

C19H23NO4 (329.1627)


   
   

Haplotubinone

Haplotubinone

C19H23NO4 (329.1627)


   

(-)-O-Methylstepharinosine

(-)-O-Methylstepharinosine

C19H23NO4 (329.1627)


   

(+)-Pallidinine

(+)-Pallidinine

C19H23NO4 (329.1627)


   

2,7-Dihydrohomoerysotrine

2,7-Dihydrohomoerysotrine

C20H27NO3 (329.1991)


   

O-Acetylgalanthamine

O-Acetylgalanthamine

C19H23NO4 (329.1627)


   

Erythrartine

11-Hydroxyerysotrine

C19H23NO4 (329.1627)


   
   

8-Isothiocyanatocycloamphilect-10-ene

8-Isothiocyanatocycloamphilect-10-ene

C21H31NS (329.2177)


   

Norsongorine

N-Deethylsongorine

C20H27NO3 (329.1991)


   

Protosinomenine

Protosinomenine

C19H23NO4 (329.1627)


   

(-)-Cepharamine

(-)-Cepharamine

C19H23NO4 (329.1627)


   

3-Epischelhammerine

3-Epischelhammerine

C19H23NO4 (329.1627)


   

Crassifolazonine

Crassifolazonine

C19H23NO4 (329.1627)


   
   

O-Methylrobustimine

O-Methylrobustimine

C19H23NO4 (329.1627)


   

Pseudokobusine

Pseudokobusine

C20H27NO3 (329.1991)


   
   
   
   

Cohirsinine

O-Demethylcohirsine

C19H23NO4 (329.1627)


   

Ilamine N-oxide

Ilamine N-oxide

C16H27NO6 (329.1838)


   
   

Erysotrine-N-oxide

Erysotrine-N-oxide

C19H23NO4 (329.1627)


   

(+)-alpha-Hydroxyerysotrine

(+)-alpha-Hydroxyerysotrine

C19H23NO4 (329.1627)


   

7-O-Methylnororientaline

7-O-Methylnororientaline

C19H23NO4 (329.1627)


   
   
   
   

XLR11 Degradant

XLR11 Degradant

C21H28FNO (329.2155)


   
   

Tralkoxydim

Tralkoxydim (isomer2)

C20H27NO3 (329.1991)


   

Fortimicin AH|Fortimicin AI

Fortimicin AH|Fortimicin AI

C15H27N3O5 (329.1951)


   

1,2,3,4-Tetrahydro-6-hydroxy-7-methoxy-1-(4-hydroxy-3-methoxybenzyl)-2-methylisoquinoline

1,2,3,4-Tetrahydro-6-hydroxy-7-methoxy-1-(4-hydroxy-3-methoxybenzyl)-2-methylisoquinoline

C19H23NO4 (329.1627)


   
   

nortropane-3alpha,7beta-diol 7-trans-cinnamate 3-propanoate

nortropane-3alpha,7beta-diol 7-trans-cinnamate 3-propanoate

C19H23NO4 (329.1627)


   

pipercallosidine|Pipercallosine

pipercallosidine|Pipercallosine

C20H27NO3 (329.1991)


   

Isorobustiline

Isorobustiline

C19H23NO4 (329.1627)


   

2-Hydroxy-3-methoxy-6-oxo-N-acetylmorphinan

2-Hydroxy-3-methoxy-6-oxo-N-acetylmorphinan

C19H23NO4 (329.1627)


   
   

Alkaloid PC-II

Alkaloid PC-II

C20H27NO3 (329.1991)


   

(-)-11,12-dihydroorientalinone

(-)-11,12-dihydroorientalinone

C19H23NO4 (329.1627)


   

(+)-crassifoline

(+)-crassifoline

C19H23NO4 (329.1627)


   

?-Annonelliptine|annonelliptine

?-Annonelliptine|annonelliptine

C19H23NO4 (329.1627)


   

Erythratidinone

Erythratidinone

C19H23NO4 (329.1627)


   

(1S,17S)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0^{1,14.0^{2,7]octadeca-2,4,6,14-tetraene

(1S,17S)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0^{1,14.0^{2,7]octadeca-2,4,6,14-tetraene

C20H27NO3 (329.1991)


   

N-[2-(4-Methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)propanamide

N-[2-(4-Methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)propanamide

C19H23NO4 (329.1627)


   

7alpha-hydroxycossonidine

7alpha-hydroxycossonidine

C20H27NO3 (329.1991)


   

N-[2-(4-Hydroxyphenyl)ethyl]-3-(3,4-dimethoxyphenyl)propanamide

N-[2-(4-Hydroxyphenyl)ethyl]-3-(3,4-dimethoxyphenyl)propanamide

C19H23NO4 (329.1627)


   

9-hydroxynominine

9-hydroxynominine

C20H27NO3 (329.1991)


   
   

11-methoxyerysodine

11-methoxyerysodine

C19H23NO4 (329.1627)


   
   

Antrocinnamomin E

Antrocinnamomin E

C19H23NO4 (329.1627)


   

8-Demethoxycephatonine

7,8-Didehydro-2-hydroxy-3,7-dimethoxy-17-methylhasubanan-6-one

C19H23NO4 (329.1627)


   

Antrocinnamomin F

Antrocinnamomin F

C19H23NO4 (329.1627)


   

N-[(3R,7R)-(+)-jasmonoyl]tyramine

N-[(3R,7R)-(+)-jasmonoyl]tyramine

C20H27NO3 (329.1991)


   
   
   

Antibiotic Tu 1718z

Antibiotic Tu 1718z

C14H23N3O6 (329.1587)


   

2,3-methanediyldioxy-6xi-methoxy-17-methyl-morphin-8(14)-en-7xi-ol|5,6-dihydro-amurinol|amurininol|Dihydroundarin

2,3-methanediyldioxy-6xi-methoxy-17-methyl-morphin-8(14)-en-7xi-ol|5,6-dihydro-amurinol|amurininol|Dihydroundarin

C19H23NO4 (329.1627)


   
   

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1-methyl-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine B

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1-methyl-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine B

C19H23NO4 (329.1627)


   
   
   

1-[7-(3,4-methylenedioxyphenyl)-(2E,4E)-heptadienoyl]-N-isobutylamide

1-[7-(3,4-methylenedioxyphenyl)-(2E,4E)-heptadienoyl]-N-isobutylamide

C20H27NO3 (329.1991)


   

cloperastine

cloperastine

C20H24ClNO (329.1546)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

SCHEMBL2742527

SCHEMBL2742527

C19H23NO4 (329.1627)


   

3-[(6-Oxodecanoyl)oxy]-4-(trimethylammonio)butanoate

3-[(6-Oxodecanoyl)oxy]-4-(trimethylammonio)butanoate

C17H31NO5 (329.2202)


   

14-Episinomenine

14-Episinomenine

C19H23NO4 (329.1627)


14-Episinomenine is a natural product found in Stephania cephalantha with data available.

   

Trilostane

Trilostane

C20H27NO3 (329.1991)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02C - Antiadrenal preparations > H02CA - Anticorticosteroids C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor > C2184 - 3-Hydroxysteroid Dehydrogenase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4414; ORIGINAL_PRECURSOR_SCAN_NO 4413 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4409; ORIGINAL_PRECURSOR_SCAN_NO 4407 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4370; ORIGINAL_PRECURSOR_SCAN_NO 4368 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4405; ORIGINAL_PRECURSOR_SCAN_NO 4404 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4411; ORIGINAL_PRECURSOR_SCAN_NO 4410 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4413; ORIGINAL_PRECURSOR_SCAN_NO 4412 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8763; ORIGINAL_PRECURSOR_SCAN_NO 8759 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9288; ORIGINAL_PRECURSOR_SCAN_NO 9285 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9297; ORIGINAL_PRECURSOR_SCAN_NO 9293 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9341; ORIGINAL_PRECURSOR_SCAN_NO 9336 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8839; ORIGINAL_PRECURSOR_SCAN_NO 8834 CONFIDENCE standard compound; INTERNAL_ID 720; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8911; ORIGINAL_PRECURSOR_SCAN_NO 8909

   

2-methoxy-phenylacryloyl-lupinine

NCGC00160250-01!2-methoxy-phenylacryloyl-lupinine

C20H27NO3 (329.1991)


   

HETISINE

NCGC00160245-01!HETISINE

C20H27NO3 (329.1991)


   

MLS000728590-01!

MLS000728590-01!

C20H27NO3 (329.1991)


   
   

(1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H28FNO (329.2155)


   

prenylamine

prenylamine

C24H27N (329.2143)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

kukoline

Sinomenine

C19H23NO4 (329.1627)


Origin: Plant; Formula(Parent): C19H23NO4; Bottle Name:Sinomenine; PRIME Parent Name:Sinomenine; PRIME in-house No.:V0298; SubCategory_DNP: Isoquinoline alkaloids, Morphine alkaloids D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D018501 - Antirheumatic Agents Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].

   

Delatine

Delatine

C20H27NO3 (329.1991)


Origin: Plant; Formula(Parent): C20H27NO3; Bottle Name:Hetisine hydrochloride; PRIME Parent Name:Hetisine; PRIME in-house No.:V0348; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

   

Decyltyrazolone

Decyltyrazolone

C20H27NO3 (329.1991)


   
   
   
   
   

N-desethyloxybutynin

N-desethyloxybutynin

C20H27NO3 (329.1991)


D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids

   
   
   
   
   
   
   
   
   
   
   
   
   
   

Retrofractamide C

(2E,8E)-9-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)nona-2,8-dienamide

C20H27NO3 (329.1991)


   

Tricholein

(8Z)-9-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one

C20H27NO3 (329.1991)


   

xi-Anomuricine

6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C19H23NO4 (329.1627)


   

Pipertipine

(7E)-8-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)oct-7-en-1-one

C20H27NO3 (329.1991)


   

CAR 10:1;O

3-[(6-oxodecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO5 (329.2202)


   

Bacillamidin A

(1?R)-9-methyldecanoyl dimethylaspartate

C17H31NO5 (329.2202)


   

8,14-Dihydrosalutaridine

(-)-8,14-dihydrosalutaridine

C19H23NO4 (329.1627)


   

Thiourea,N-(2-methoxyphenyl)-N-(1-methylethyl)-N-[1-(2-pyridinyl)ethyl]-

Thiourea,N-(2-methoxyphenyl)-N-(1-methylethyl)-N-[1-(2-pyridinyl)ethyl]-

C18H23N3OS (329.1562)


   

4-(4-DIETHYLAMINOPHENYLIMINO)-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBONITRILE

4-(4-DIETHYLAMINOPHENYLIMINO)-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBONITRILE

C21H19N3O (329.1528)


   

butyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

butyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

C16H27NO6 (329.1838)


   

(S)-2-Amino-5-methoxytetralin (S)-mandelate

(S)-2-Amino-5-methoxytetralin (S)-mandelate

C19H23NO4 (329.1627)


   

4-TERT-BUTYL-2-(3-CHLOROPHENYL)-2-(PHENYLETHYL)-MORPHOLINE

4-TERT-BUTYL-2-(3-CHLOROPHENYL)-2-(PHENYLETHYL)-MORPHOLINE

C20H24ClNO (329.1546)


   

9,10-Ethanoanthracene-9(10H)-ethanol,a-[(methylamino)methyl]-,hydrochloride (1:1)

9,10-Ethanoanthracene-9(10H)-ethanol,a-[(methylamino)methyl]-,hydrochloride (1:1)

C20H24ClNO (329.1546)


   
   

a-(3-quinuclidinyl)benzhydrol

a-(3-quinuclidinyl)benzhydrol

C20H24ClNO (329.1546)


   

4-[2-[benzyl(tert-butyl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol

4-[2-[benzyl(tert-butyl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol

C20H27NO3 (329.1991)


   

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-NAPHTHALEN-2-YL-PROPIONIC ACID METHYL ESTER

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-NAPHTHALEN-2-YL-PROPIONIC ACID METHYL ESTER

C19H23NO4 (329.1627)


   

Boc-L-glutamic acid 5-cyclohexyl ester

Boc-L-glutamic acid 5-cyclohexyl ester

C16H27NO6 (329.1838)


   

4-Benzyl Albuterol

4-Benzyl Albuterol

C20H27NO3 (329.1991)


   

1-BOC-4-[2-(1H-INDOL-3-YL)-ETHYL]-PIPERAZINE

1-BOC-4-[2-(1H-INDOL-3-YL)-ETHYL]-PIPERAZINE

C19H27N3O2 (329.2103)


   

2-ethylhexyl (E)-3-(1,3-benzodioxol-5-yl)-2-cyanoprop-2-enoate

2-ethylhexyl (E)-3-(1,3-benzodioxol-5-yl)-2-cyanoprop-2-enoate

C19H23NO4 (329.1627)


   

(3-FLUOROPHENYL)[2-NITRO-4-[(PIPERIDIN-1-YL)METHYL]PHENYL]AMINE

(3-FLUOROPHENYL)[2-NITRO-4-[(PIPERIDIN-1-YL)METHYL]PHENYL]AMINE

C18H20FN3O2 (329.1539)


   
   

sodium 2-[(1-oxododecyl)amino]ethanesulphonate

sodium 2-[(1-oxododecyl)amino]ethanesulphonate

C14H28NNaO4S (329.1637)


   

1-tert-butyl 4,4-diethyl piperidine-1,4,4-tricarboxylate

1-tert-butyl 4,4-diethyl piperidine-1,4,4-tricarboxylate

C16H27NO6 (329.1838)


   

H-Tyr(tBu)-OtBu.HCl

H-Tyr(tBu)-OtBu.HCl

C17H28ClNO3 (329.1758)


   

Pramoxine HCl

Pramoxine Hydrochloride

C17H28ClNO3 (329.1758)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

N-Acetyl-Val-Ala-Asp-al

N-Acetyl-Val-Ala-Asp-al

C14H23N3O6 (329.1587)


   

buta-1,3-diene,prop-2-enenitrile,prop-1-en-2-ylbenzene,styrene

buta-1,3-diene,prop-2-enenitrile,prop-1-en-2-ylbenzene,styrene

C24H27N (329.2143)


   

Pivopril

Pivopril

C16H27NO4S (329.1661)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

   

Butriptyline hydrochloride

Butriptyline hydrochloride

C21H28ClN (329.191)


   
   

Boc-(S)-3-Amino-4-(2-naphthyl)-butyric acid

Boc-(S)-3-Amino-4-(2-naphthyl)-butyric acid

C19H23NO4 (329.1627)


   

(S)-5-METHOXY-N-PROPYL-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

(S)-5-METHOXY-N-PROPYL-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

C20H27NOS (329.1813)


   

N-(3,4-Dimethoxyphenethyl)-2-(4-methoxyphenyl)acetamide

N-(3,4-Dimethoxyphenethyl)-2-(4-methoxyphenyl)acetamide

C19H23NO4 (329.1627)


   

L-Glutamic acid,N-(1-oxododecyl)-

L-Glutamic acid,N-(1-oxododecyl)-

C17H31NO5 (329.2202)


   

3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-phenyl-, 3,5-diethyl ester

3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-phenyl-, 3,5-diethyl ester

C19H23NO4 (329.1627)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-methoxyphenyl)acetamide

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-methoxyphenyl)acetamide

C19H23NO4 (329.1627)


   

Boc-(R)-3-Amino-4-(1-naphthyl)-butyric acid

Boc-(R)-3-Amino-4-(1-naphthyl)-butyric acid

C19H23NO4 (329.1627)


   

Boc-(R)-3-Amino-4-(2-naphthyl)-butyric acid

Boc-(R)-3-Amino-4-(2-naphthyl)-butyric acid

C19H23NO4 (329.1627)


   

N-BENZOYLMEROQUINENE TERT-BUTYL ESTER

N-BENZOYLMEROQUINENE TERT-BUTYL ESTER

C20H27NO3 (329.1991)


   

5-METHOXY-1,3,4-TRIPHENYL-4,5-DIHYDRO-1H-1,2,4-TRIAZOLIN

5-METHOXY-1,3,4-TRIPHENYL-4,5-DIHYDRO-1H-1,2,4-TRIAZOLIN

C21H19N3O (329.1528)


   

H-Lys-Phe-OH · HCl

H-Lys-Phe-OH · HCl

C15H24ClN3O3 (329.1506)


   

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-methoxyphenyl)-1-piperazinyl]

Methanone, (3-ethyl-5-methyl-4-isoxazolyl)[4-(4-methoxyphenyl)-1-piperazinyl]

C18H23N3O3 (329.1739)


   

(2E)-1-(4-BROMOPHENYL)-3-PHENYLPROP-2-EN-1-ONE

(2E)-1-(4-BROMOPHENYL)-3-PHENYLPROP-2-EN-1-ONE

C23H23NO (329.178)


   

tert-butyl 3-(5-phenyl-1,2,4-oxadiazol-3-yl)piperidine-1-carboxylate

tert-butyl 3-(5-phenyl-1,2,4-oxadiazol-3-yl)piperidine-1-carboxylate

C18H23N3O3 (329.1739)


   

(S)-2 Azido-3-(3-indolyl)propionic acid cyclohexylamMonium salt

(S)-2 Azido-3-(3-indolyl)propionic acid cyclohexylamMonium salt

C17H23N5O2 (329.1852)


   

2-[3-(1-carbamoyl-1-methylethyl)-5-[1,2,4]triazol-1-ylmethylphenyl]-isobutyramide

2-[3-(1-carbamoyl-1-methylethyl)-5-[1,2,4]triazol-1-ylmethylphenyl]-isobutyramide

C17H23N5O2 (329.1852)


   

5FUR-144

(1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

C21H28FNO (329.2155)


   

1-ISOTHIOCYANATO-4-(TRANS-4-OCTYLCYCLO-H EXYL)BENZENE

1-ISOTHIOCYANATO-4-(TRANS-4-OCTYLCYCLO-H EXYL)BENZENE

C21H31NS (329.2177)


   

1-(TERT-BUTOXYCARBONYL)SPIRO[INDENE-1,4-PIPERIDINE]-3-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)SPIRO[INDENE-1,4-PIPERIDINE]-3-CARBOXYLIC ACID

C19H23NO4 (329.1627)


   

4-N-BOC-AMINOMETHYL-1-N-BOC-PYRROLIDIN-3-ONE OXIME

4-N-BOC-AMINOMETHYL-1-N-BOC-PYRROLIDIN-3-ONE OXIME

C15H27N3O5 (329.1951)


   

TERT-BUTYL 3-(4-METHOXYPHENYL)-6,7-DIHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-5(4H)-CARBOXYLATE

TERT-BUTYL 3-(4-METHOXYPHENYL)-6,7-DIHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-5(4H)-CARBOXYLATE

C18H23N3O3 (329.1739)


   

2,6-Bis[(4S)-4-tert-butyloxazolin-2-yl]pyridine

2,6-Bis[(4S)-4-tert-butyloxazolin-2-yl]pyridine

C19H27N3O2 (329.2103)


   

2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZONITRILE

2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZONITRILE

C18H24BNO4 (329.1798)


   

Boc-(S)-3-Amino-4-(1-naphthyl)-butyric acid

Boc-(S)-3-Amino-4-(1-naphthyl)-butyric acid

C19H23NO4 (329.1627)


   

6,7-dimethoxy-2-(4-prop-2-enylpiperazin-1-yl)quinazolin-4-amine

6,7-dimethoxy-2-(4-prop-2-enylpiperazin-1-yl)quinazolin-4-amine

C17H23N5O2 (329.1852)


   

2,6-Bis[(4R)-4-tert-butyl-2-oxazolin-2-yl]pyridine

2,6-Bis[(4R)-4-tert-butyl-2-oxazolin-2-yl]pyridine

C19H27N3O2 (329.2103)


   
   

cobalt(2+),1,2,3,5,5-pentamethylcyclopenta-1,3-diene

cobalt(2+),1,2,3,5,5-pentamethylcyclopenta-1,3-diene

C20H30Co (329.1679)


   

Methanone, (4-​methyl-​1-​piperidinyl)​[3-​(4,​4,​5,​5-​tetramethyl-​1,​3,​2-​dioxaborolan-​2-​yl)​phenyl]​-

Methanone, (4-​methyl-​1-​piperidinyl)​[3-​(4,​4,​5,​5-​tetramethyl-​1,​3,​2-​dioxaborolan-​2-​yl)​phenyl]​-

C19H28BNO3 (329.2162)


   

2-Benzyl 4-(2-methyl-2-propanyl) 3,5-dimethyl-1H-pyrrole-2,4-dica rboxylate

2-Benzyl 4-(2-methyl-2-propanyl) 3,5-dimethyl-1H-pyrrole-2,4-dica rboxylate

C19H23NO4 (329.1627)


   

(R)-De(aminosulfonyl) Tamsulosin

(R)-De(aminosulfonyl) Tamsulosin

C20H27NO3 (329.1991)


   

Malachite green cation

Malachite green cation

C23H25N2+ (329.2018)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes D000890 - Anti-Infective Agents D016573 - Agrochemicals D010575 - Pesticides

   

Bavisant

Bavisant

C19H27N3O2 (329.2103)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Bavisant (JNJ-31001074) is an orally active, potent, brain-penetrating and highly selective antagonist of the histamine H3 receptor. Bavisant can be used for attention-deficit hyperactivity disorder (ADHD) research[1][2][3].

   

2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (1-dimethylcarbamoyl-2,2-dimethyl-propyl)-amide

2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (1-dimethylcarbamoyl-2,2-dimethyl-propyl)-amide

C16H31N3O4 (329.2314)


   

Aspyridone A

Aspyridone A

C19H23NO4 (329.1627)


2-Pyridone carrying as substituents a branched dimethylhexanoyl group, a hydroxy group and a p-hydroxyphenyl group at C-3, -4 and -5 respectively. Secondary metabolite produced by Aspergillus spp.

   

N-lauroyl-DL-glutamic acid

N-lauroyl-DL-glutamic acid

C17H31NO5 (329.2202)


   

6-Alpha Naloxol

6-Alpha Naloxol

C19H23NO4 (329.1627)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo(3.3.1.13,7)dec-1-yl-, (1R,3S)-

1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo(3.3.1.13,7)dec-1-yl-, (1R,3S)-

C20H27NO3 (329.1991)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

L-tryptophan beta-naphthylamide

L-tryptophan beta-naphthylamide

C21H19N3O (329.1528)


   

(3-Amino-5,6,7,8,9,10-hexahydrocycloocta[b]thieno[3,2-e]pyridin-2-yl)(pyrrolidin-1-yl)methanone

(3-Amino-5,6,7,8,9,10-hexahydrocycloocta[b]thieno[3,2-e]pyridin-2-yl)(pyrrolidin-1-yl)methanone

C18H23N3OS (329.1562)


   

XLR11 N-(2-fluoropentyl) isomer

XLR11 N-(2-fluoropentyl) isomer

C21H28FNO (329.2155)


   

N-[3-(2-methylcyclohexyl)-2,4-dihydro-1H-1,3,5-triazin-6-yl]-1,3-benzothiazol-2-amine

N-[3-(2-methylcyclohexyl)-2,4-dihydro-1H-1,3,5-triazin-6-yl]-1,3-benzothiazol-2-amine

C17H23N5S (329.1674)


   

3-(2-Piperidin-1-yl-acetylamino)-1H-indole-2-carboxylic acid ethyl ester

3-(2-Piperidin-1-yl-acetylamino)-1H-indole-2-carboxylic acid ethyl ester

C18H23N3O3 (329.1739)


   

2-Methyl-4-[2-(4-phenylcyclohexylidene)hydrazin-1-yl]quinoline

2-Methyl-4-[2-(4-phenylcyclohexylidene)hydrazin-1-yl]quinoline

C22H23N3 (329.1892)


   

New fuchsin free base

New fuchsin free base

C22H23N3 (329.1892)


   

(2S)-2-[[(2S)-3-methyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoyl]amino]butanedioic Acid

(2S)-2-[[(2S)-3-methyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoyl]amino]butanedioic Acid

C14H23N3O6 (329.1587)


   

L-Leucyl-L-prolyl-L-threonine

L-Leucyl-L-prolyl-L-threonine

C15H27N3O5 (329.1951)


   
   

6-Amino-2-[(2-Morpholin-4-Ylethyl)amino]-3,7-Dihydro-8h-Imidazo[4,5-G]quinazolin-8-One

6-Amino-2-[(2-Morpholin-4-Ylethyl)amino]-3,7-Dihydro-8h-Imidazo[4,5-G]quinazolin-8-One

C15H19N7O2 (329.16)


   

Gabapentin enacarbil

Gabapentin enacarbil

C16H27NO6 (329.1838)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Dapivirine

Dapivirine (TMC120)

C20H19N5 (329.164)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

CHEBI:17428

(1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol

C19H23NO4 (329.1627)


   

2,11,12-Trimethoxy-1,2,5,6,8,9-hexahydroindolo[7a,1-a]isoquinolin-3-one

2,11,12-Trimethoxy-1,2,5,6,8,9-hexahydroindolo[7a,1-a]isoquinolin-3-one

C19H23NO4 (329.1627)


   

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Leu-OH

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Leu-OH

C14H23N3O6 (329.1587)


   

(R)-isoorientaline

(R)-isoorientaline

C19H23NO4 (329.1627)


   

(S)-isoorientaline

(S)-isoorientaline

C19H23NO4 (329.1627)


   
   

gibberellin A15 (closed lactone form)

gibberellin A15 (closed lactone form)

C20H25O4- (329.1753)


   

(2R,3S)-2-hydroxytridecane-1,2,3-tricarboxylate

(2R,3S)-2-hydroxytridecane-1,2,3-tricarboxylate

C16H25O7-3 (329.16)


   

4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-2-methoxyphenol

4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-2-methoxyphenol

C19H23NO4 (329.1627)


   

1-[(8E)-9-(3,4-methylenedioxyphenyl)-8-nonenoyl]pyrrolidine

1-[(8E)-9-(3,4-methylenedioxyphenyl)-8-nonenoyl]pyrrolidine

C20H27NO3 (329.1991)


A natural product found in Piper boehmeriaefolium.

   

17-Hydroxy-10-methoxy-4-(methylamino)-12-oxapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one

17-Hydroxy-10-methoxy-4-(methylamino)-12-oxapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one

C19H23NO4 (329.1627)


   

3-oxodecanoylcarnitine

3-oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

9-Oxodecanoylcarnitine

9-Oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

7-Oxodecanoylcarnitine

7-Oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

5-Oxodecanoylcarnitine

5-Oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

4-Oxodecanoylcarnitine

4-Oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

8-Oxodecanoylcarnitine

8-Oxodecanoylcarnitine

C17H31NO5 (329.2202)


   

Non-5-enedioylcarnitine

Non-5-enedioylcarnitine

C16H27NO6 (329.1838)


   

Non-6-enedioylcarnitine

Non-6-enedioylcarnitine

C16H27NO6 (329.1838)


   

5-Hydroxydec-3-enoylcarnitine

5-Hydroxydec-3-enoylcarnitine

C17H31NO5 (329.2202)


   

5-Hydroxydec-8-enoylcarnitine

5-Hydroxydec-8-enoylcarnitine

C17H31NO5 (329.2202)


   

5-Hydroxydec-5-enoylcarnitine

5-Hydroxydec-5-enoylcarnitine

C17H31NO5 (329.2202)


   

5-Hydroxydec-6-enoylcarnitine

5-Hydroxydec-6-enoylcarnitine

C17H31NO5 (329.2202)


   

5-Hydroxydec-7-enoylcarnitine

5-Hydroxydec-7-enoylcarnitine

C17H31NO5 (329.2202)


   

5-Hydroxydec-4-enoylcarnitine

5-Hydroxydec-4-enoylcarnitine

C17H31NO5 (329.2202)


   

(2E)-Non-2-enedioylcarnitine

(2E)-Non-2-enedioylcarnitine

C16H27NO6 (329.1838)


   

(2Z)-5-Hydroxydec-2-enoylcarnitine

(2Z)-5-Hydroxydec-2-enoylcarnitine

C17H31NO5 (329.2202)


   

Pipercallosine

Pipercallosine

C20H27NO3 (329.1991)


An alkaloid enamide that is (2E,4E)-N-(2-methylpropyl)nona-2,4-dienamide substituted at position 9 by a 1,3-benzodioxol-5-yl group. Isolated from Piper sarmentosum, it has been found to induce apoptosis in HT-29 cells.

   
   

4-[3-(Dimethylamino)propylamino]-7,8-dimethyl-3-quinolinecarboxylic acid ethyl ester

4-[3-(Dimethylamino)propylamino]-7,8-dimethyl-3-quinolinecarboxylic acid ethyl ester

C19H27N3O2 (329.2103)


   

1-[3-[3-(3-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-1-butanone

1-[3-[3-(3-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-1-butanone

C18H23N3O3 (329.1739)


   

[3-[(2-Methylphenyl)methyl]-1-[(5-methyl-2-thiophenyl)methyl]-3-piperidinyl]methanol

[3-[(2-Methylphenyl)methyl]-1-[(5-methyl-2-thiophenyl)methyl]-3-piperidinyl]methanol

C20H27NOS (329.1813)


   

1-(1,5-dimethyl-3-pyrazolyl)-N-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]methanamine

1-(1,5-dimethyl-3-pyrazolyl)-N-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]methanamine

C17H20FN5O (329.1652)


   

(7R)-salutaridinol

(7R)-salutaridinol

C19H23NO4 (329.1627)


   

3,6-Dimethoxy-17-methyl-5,6,8,14-tetradehydromorphinan-4,7-diol

3,6-Dimethoxy-17-methyl-5,6,8,14-tetradehydromorphinan-4,7-diol

C19H23NO4 (329.1627)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide

N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide

C20H24FNO2 (329.1791)


   

3-(4-Methoxyphenyl)-2,5-dimethyl-7-phenylpyrazolo[1,5-a]pyrimidine

3-(4-Methoxyphenyl)-2,5-dimethyl-7-phenylpyrazolo[1,5-a]pyrimidine

C21H19N3O (329.1528)


   

3-Ethyl-2-[2-(2-methyl-1H-indol-3-yl)-vinyl]-3H-quinazolin-4-one

3-Ethyl-2-[2-(2-methyl-1H-indol-3-yl)-vinyl]-3H-quinazolin-4-one

C21H19N3O (329.1528)


   

1-[1-[Oxo(1-pyrrolidinyl)methyl]cyclohexyl]-3-(phenylmethyl)urea

1-[1-[Oxo(1-pyrrolidinyl)methyl]cyclohexyl]-3-(phenylmethyl)urea

C19H27N3O2 (329.2103)


   

N-(2,3-dimethylphenyl)-1-methyl-9H-pyrido[3,4-b]indole-3-carboxamide

N-(2,3-dimethylphenyl)-1-methyl-9H-pyrido[3,4-b]indole-3-carboxamide

C21H19N3O (329.1528)


   

2-(3-bicyclo[2.2.1]heptanyl)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethanone

2-(3-bicyclo[2.2.1]heptanyl)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethanone

C20H27NO3 (329.1991)


   

(2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylate

(2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylate

C16H25O7-3 (329.16)


   

3-[5-(4-Methoxyphenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

3-[5-(4-Methoxyphenyl)-1-(2-oxolanylmethyl)-2-pyrrolyl]propanoic acid

C19H23NO4 (329.1627)


   

1-methyl-N,N-bis(trimethylsilyl)-5-[(trimethylsilyl)oxy]imidazol-2-amine

1-methyl-N,N-bis(trimethylsilyl)-5-[(trimethylsilyl)oxy]imidazol-2-amine

C13H31N3OSi3 (329.1775)


   
   

3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-leucine

3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-leucine

C14H23N3O6 (329.1587)


   

2-(3,4-dimethylphenyl)-4-(1H-indol-3-ylmethylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one

2-(3,4-dimethylphenyl)-4-(1H-indol-3-ylmethylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one

C21H19N3O (329.1528)


   
   
   
   
   
   
   

(S)-1-(1-(1-(2-amino-9H-purin-6-yl)piperidin-4-yl)-1H-1,2,3-triazol-4-yl)ethanol

(S)-1-(1-(1-(2-amino-9H-purin-6-yl)piperidin-4-yl)-1H-1,2,3-triazol-4-yl)ethanol

C14H19N9O (329.1712)


   

(1,2-Dimethyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

(1,2-Dimethyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

C22H21N2O+ (329.1654)


   

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C18H23N3O3 (329.1739)


   
   
   
   
   
   
   
   
   
   

All-trans-4-oxo-16-hydroxyretinoate

All-trans-4-oxo-16-hydroxyretinoate

C20H25O4- (329.1753)


   

All-trans-4-oxo-18-hydroxyretinoate

All-trans-4-oxo-18-hydroxyretinoate

C20H25O4- (329.1753)


   

(2E)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undec-2-enoate

(2E)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undec-2-enoate

C17H29O6- (329.1964)


   

(E,10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundec-2-enoate

(E,10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundec-2-enoate

C17H29O6- (329.1964)


   

(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

C19H23NO4 (329.1627)


   

N-Piperoyl-N,N-dibutylamine

N-Piperoyl-N,N-dibutylamine

C20H27NO3 (329.1991)


   

Psedokobusine

Psedokobusine

C20H27NO3 (329.1991)


   

[(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl (Z)-3-(2-methoxyphenyl)prop-2-enoate

[(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl (Z)-3-(2-methoxyphenyl)prop-2-enoate

C20H27NO3 (329.1991)


   

(1S,3S,5R,8R,9R,10R,11R,14R,16R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

(1S,3S,5R,8R,9R,10R,11R,14R,16R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

(1R,2R,6R,8S,11S,12S,15R,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile

(1R,2R,6R,8S,11S,12S,15R,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile

C20H27NO3 (329.1991)


   

N-Acetyl-alanyl-leucyl-alanine methylester

N-Acetyl-alanyl-leucyl-alanine methylester

C15H27N3O5 (329.1951)


   

(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid tert-butyl ester

(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid tert-butyl ester

C17H31NO5 (329.2202)


   

(1S,3S,5R,8R,10R,11R,14R,16R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

(1S,3S,5R,8R,10R,11R,14R,16R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

(1S,3S,5R,8R,9R,10R,11R,14R,16R,17R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

(1S,3S,5R,8R,9R,10R,11R,14R,16R,17R,19S)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

Delatine (Hetisine)

Delatine (Hetisine)

C20H27NO3 (329.1991)


   

methyl (3S,4R)-8-methyl-3-[(E)-3-phenylprop-2-enoyl]oxy-8-azabicyclo[3.2.1]octane-4-carboxylate

methyl (3S,4R)-8-methyl-3-[(E)-3-phenylprop-2-enoyl]oxy-8-azabicyclo[3.2.1]octane-4-carboxylate

C19H23NO4 (329.1627)


   

2-[(2-amino-3-methylbutanoyl)amino]-3-hydroxy-4-[(3S,5S)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

2-[(2-amino-3-methylbutanoyl)amino]-3-hydroxy-4-[(3S,5S)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

C14H23N3O6 (329.1587)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Promethazine hydroxyethyl

Promethazine hydroxyethyl

C19H25N2OS+ (329.1688)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives

   

6-Keto-decanoylcarnitine

6-Keto-decanoylcarnitine

C17H31NO5 (329.2202)


   

4-Hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one

4-Hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one

C19H23NO4 (329.1627)


   

6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C19H23NO4 (329.1627)


   

(8E)-Piperamide-C9:1

(8E)-Piperamide-C9:1

C20H27NO3 (329.1991)


   

oscr#17(1-)

oscr#17(1-)

C17H29O6 (329.1964)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#17, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#17(1-)

ascr#17(1-)

C17H29O6 (329.1964)


Conjugate base of ascr#17

   

Leu-FMDP

Leu-FMDP

C14H23N3O6 (329.1587)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-leucine joined by peptide linkages.

   

(7S)-salutaridinol

(7S)-salutaridinol

C19H23NO4 (329.1627)


   

[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

C21H28FNO (329.2155)


   
   
   

NA-Cys 14:1(9Z)

NA-Cys 14:1(9Z)

C17H31NO3S (329.2025)


   
   

CAR 10:0;6oxo

CAR 10:0;6oxo

C17H31NO5 (329.2202)


   
   
   
   
   

(1r,4s,5r)-4-hydroxy-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),9,14(18)-trien-8-one

(1r,4s,5r)-4-hydroxy-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),9,14(18)-trien-8-one

C19H23NO4 (329.1627)


   

(1s,19s,20r)-20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

(1s,19s,20r)-20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

C19H23NO4 (329.1627)


   

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C19H23NO4 (329.1627)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,15,19-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,15,19-triol

C20H27NO3 (329.1991)


   

7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

C19H23NO4 (329.1627)


   

(1r,9r,10s)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1r,9r,10s)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C19H23NO4 (329.1627)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

C20H27NO3 (329.1991)


   

methyl (1r,2r,3s,5s)-8-methyl-3-{[(2e)-3-phenylprop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octane-2-carboxylate

methyl (1r,2r,3s,5s)-8-methyl-3-{[(2e)-3-phenylprop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octane-2-carboxylate

C19H23NO4 (329.1627)


   

(1s,9s,10r)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1s,9s,10r)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(1s,3s,5r,8r,9s,10r,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

(1s,3s,5r,8r,9s,10r,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

(1r,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1r,4's)-11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C19H23NO4 (329.1627)


   

(1s,2r,5r,8r,9s,11r,13r,14r,15s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

(1s,2r,5r,8r,9s,11r,13r,14r,15s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

C20H27NO3 (329.1991)


   

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraene

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraene

C20H27NO3 (329.1991)


   

(1s,17r)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

(1s,17r)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

C20H27NO3 (329.1991)


   

(1s,9r,10s)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1s,9r,10s)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(2r,5e)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-7-hydroxy-6-methylhept-5-enoic acid

(2r,5e)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-7-hydroxy-6-methylhept-5-enoic acid

C15H27N3O5 (329.1951)


   

(1s,3ar,3a¹s,4s,5as,5a¹s,10as)-10a-isothiocyanato-1,4,7,7-tetramethyl-1,2,3,3a,3a¹,4,5,5a,5a¹,6,8,10-dodecahydropyrene

(1s,3ar,3a¹s,4s,5as,5a¹s,10as)-10a-isothiocyanato-1,4,7,7-tetramethyl-1,2,3,3a,3a¹,4,5,5a,5a¹,6,8,10-dodecahydropyrene

C21H31NS (329.2177)


   

(1r,13r,15s,18r)-4,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-5-ol

(1r,13r,15s,18r)-4,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-5-ol

C19H23NO4 (329.1627)


   

3-epimethylschelhammericine b

NA

C20H27NO3 (329.1991)


{"Ingredient_id": "HBIN008489","Ingredient_name": "3-epimethylschelhammericine b","Alias": "NA","Ingredient_formula": "C20H27NO3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6968","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-vinyl-1,2- dimethyl-1,4-cyclohexadiene

NA

C20H27NO3 (329.1991)


{"Ingredient_id": "HBIN009754","Ingredient_name": "3-vinyl-1,2- dimethyl-1,4-cyclohexadiene","Alias": "NA","Ingredient_formula": "C20H27NO3","Ingredient_Smile": "CC1(COC(=N1)C2=CC=C(C(C2C=C)(C)C(=O)CCC=C)OC)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42372","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,4-dienimidic acid

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,4-dienimidic acid

C20H27NO3 (329.1991)


   

n-[2-(4-hydroxyphenyl)ethyl]-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethanimidic acid

n-[2-(4-hydroxyphenyl)ethyl]-2-[(1r,2r)-3-oxo-2-[(2z)-pent-2-en-1-yl]cyclopentyl]ethanimidic acid

C20H27NO3 (329.1991)


   

(1s,4s,12s,13s,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

(1s,4s,12s,13s,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

C20H27NO3 (329.1991)


   

(2s,4s)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-2,4-dimethylhexan-1-one

(2s,4s)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-2,4-dimethylhexan-1-one

C19H23NO4 (329.1627)


   

(2r,3s)-2'-hydroxy-3-[(3r)-2-hydroxy-2,6-dimethylhept-5-en-3-yl]spiro[oxirane-2,3'-quinolin]-4'-one

(2r,3s)-2'-hydroxy-3-[(3r)-2-hydroxy-2,6-dimethylhept-5-en-3-yl]spiro[oxirane-2,3'-quinolin]-4'-one

C19H23NO4 (329.1627)


   

(1s,14s,17r)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraene

(1s,14s,17r)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,15-tetraene

C20H27NO3 (329.1991)


   

(1r,9r,10s)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1r,9r,10s)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(2e,5s,9s)-15,16-dimethoxy-10-methyl-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

(2e,5s,9s)-15,16-dimethoxy-10-methyl-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

C19H23NO4 (329.1627)


   

1-hydroxy-3-{4-[(2-methylbut-3-en-2-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrole-2,5-dione

1-hydroxy-3-{4-[(2-methylbut-3-en-2-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrole-2,5-dione

C19H23NO4 (329.1627)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)non-8-en-1-one

C20H27NO3 (329.1991)


   

(1r,3s,5r,8r,9s,10s,11s,14r,16r,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-triol

(1r,3s,5r,8r,9s,10s,11s,14r,16r,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-triol

C20H27NO3 (329.1991)


   

20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

C19H23NO4 (329.1627)


   

(1s,3s,5s,8r,9s,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

(1s,3s,5s,8r,9s,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

(1r,5r,8r,9s,10r,11s,13r,14s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,16-triol

(1r,5r,8r,9s,10r,11s,13r,14s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,16-triol

C20H27NO3 (329.1991)


   

(1s,3s,5r,6s)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2z)-3-phenylprop-2-enoate

(1s,3s,5r,6s)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2z)-3-phenylprop-2-enoate

C19H23NO4 (329.1627)


   

1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C19H23NO4 (329.1627)


   

(9bs,11r)-7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

(9bs,11r)-7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C19H23NO4 (329.1627)


   

(2e,4e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,4-dienimidic acid

(2e,4e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,4-dienimidic acid

C20H27NO3 (329.1991)


   

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropylidene)pyrrolidine-2,5-dione

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropylidene)pyrrolidine-2,5-dione

C19H23NO4 (329.1627)


   

(1s)-2-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-6-ol

(1s)-2-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C19H23NO4 (329.1627)


   

4-hydroxy-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),9,14(18)-trien-8-one

4-hydroxy-5-methoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),9,14(18)-trien-8-one

C19H23NO4 (329.1627)


   

(1r,2s,5r,7r,8r,9r,10s,13r,16s,17r)-7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

(1r,2s,5r,7r,8r,9r,10s,13r,16s,17r)-7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

C20H27NO3 (329.1991)


   

(1s,4r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,4r,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

(1s,19r,20r)-20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

(1s,19r,20r)-20-methoxy-5,7-dioxa-14-azapentacyclo[12.7.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9,17-tetraen-19-ol

C19H23NO4 (329.1627)


   

(1s,9r,10r)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1s,9r,10r)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

8-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)octa-2,4-dienimidic acid

8-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)octa-2,4-dienimidic acid

C20H27NO3 (329.1991)


   

4,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-5-ol

4,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-5-ol

C19H23NO4 (329.1627)


   

(2e,4e)-8-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)octa-2,4-dienimidic acid

(2e,4e)-8-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)octa-2,4-dienimidic acid

C20H27NO3 (329.1991)


   

(5r,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

(5r,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

C19H23NO4 (329.1627)


   

(1s,5r,8r,9s,10s,11r,14r,15s,16r,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,15,19-triol

(1s,5r,8r,9s,10s,11r,14r,15s,16r,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,15,19-triol

C20H27NO3 (329.1991)


   

(1s)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

(1s)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C19H23NO4 (329.1627)


   

1-hydroxy-3-[3-hydroxy-4-(2-methylbut-3-en-2-yl)phenyl]-4-(2-methylpropyl)pyrrole-2,5-dione

1-hydroxy-3-[3-hydroxy-4-(2-methylbut-3-en-2-yl)phenyl]-4-(2-methylpropyl)pyrrole-2,5-dione

C19H23NO4 (329.1627)


   

(7as)-1-({[(2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7as)-1-({[(2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C19H23NO4 (329.1627)


   

(1s,11s,13r,16s,18s)-18-methoxy-11,15-dimethyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraene

(1s,11s,13r,16s,18s)-18-methoxy-11,15-dimethyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraene

C19H23NO4 (329.1627)


   

n-[2-(4-hydroxyphenyl)ethyl]-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethanimidic acid

n-[2-(4-hydroxyphenyl)ethyl]-2-[3-oxo-2-(pent-2-en-1-yl)cyclopentyl]ethanimidic acid

C20H27NO3 (329.1991)


   

(1s,9s,10r)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1s,9s,10r)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(1s,3s,5r,8r,9s,10s,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

(1s,3s,5r,8r,9s,10s,11r,14r,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

C20H27NO3 (329.1991)


   

2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-4-[(3s,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-hydroxy-4-[(3s,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

C14H23N3O6 (329.1587)


   

4,16-dimethoxy-10-methyl-10-azatricyclo[11.4.0.0²,⁷]heptadeca-1(13),2,4,6,14,16-hexaene-3,15-diol

4,16-dimethoxy-10-methyl-10-azatricyclo[11.4.0.0²,⁷]heptadeca-1(13),2,4,6,14,16-hexaene-3,15-diol

C19H23NO4 (329.1627)


   

(1r,17s,19r,21r)-21-methoxy-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-triene

(1r,17s,19r,21r)-21-methoxy-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-triene

C19H23NO4 (329.1627)


   

(5s,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

(5s,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

C19H23NO4 (329.1627)


   

(1r,3s,5s,8r,9s,11s,13r,14s,16s,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,13,18-triol

(1r,3s,5s,8r,9s,11s,13r,14s,16s,17r,18r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,13,18-triol

C20H27NO3 (329.1991)


   

(1s,9r,10s)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1s,9r,10s)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(3r,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

(3r,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

C19H23NO4 (329.1627)


   

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-hydroxy-4-[(3s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-hydroxy-4-[(3s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]butanoic acid

C14H23N3O6 (329.1587)


   

(1r,5s,8r,9s,11s,13r,14s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,16-triol

(1r,5s,8r,9s,11s,13r,14s,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,16-triol

C20H27NO3 (329.1991)


   

11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

11'-hydroxy-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C19H23NO4 (329.1627)


   

7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

C20H27NO3 (329.1991)


   

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-hydroxy-4-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}butanoic acid

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-hydroxy-4-{7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl}butanoic acid

C14H23N3O6 (329.1587)


   

(1s,5r,8r,9s,10r,11r,13r,14s,16s,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,19-triol

(1s,5r,8r,9s,10r,11r,13r,14s,16s,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,13,19-triol

C20H27NO3 (329.1991)


   

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7ar)-1-hydroxy-7-({[(2s)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,15,19-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-10,15,19-triol

C20H27NO3 (329.1991)


   

8-hydroxy-3,9-dimethoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

8-hydroxy-3,9-dimethoxy-,,2,3,4,11-hexahydro-h-5a-azatetraphen-6-one

C19H23NO4 (329.1627)


   

(1r)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

(1r)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C19H23NO4 (329.1627)


   

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,8-dienimidic acid

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,8-dienimidic acid

C20H27NO3 (329.1991)


   

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

C20H27NO3 (329.1991)


   

3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(1r,5s,8r,9s,11r,13r,14r,16r,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,16,19-triol

(1r,5s,8r,9s,11r,13r,14r,16r,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,16,19-triol

C20H27NO3 (329.1991)


   

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrole-2,5-dione

1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropyl)pyrrole-2,5-dione

C19H23NO4 (329.1627)


   

7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-ol

C19H23NO4 (329.1627)


   

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

(1s)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

C19H23NO4 (329.1627)


   

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

C19H23NO4 (329.1627)


   

(5r,9bs,11r)-5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

(5r,9bs,11r)-5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

C19H23NO4 (329.1627)


   

1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-2,4-dimethylhexan-1-one

1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-2,4-dimethylhexan-1-one

C19H23NO4 (329.1627)


   

(1r)-1-[(4-hydroxyphenyl)methyl]-5,6-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

(1r)-1-[(4-hydroxyphenyl)methyl]-5,6-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C19H23NO4 (329.1627)


   

(1s)-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

(1s)-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol

C19H23NO4 (329.1627)


   

acetaldehyde ammonia; isolysergic acid

acetaldehyde ammonia; isolysergic acid

C18H23N3O3 (329.1739)


   

(1s,5r,8s,9s,11r,13r,14s,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

(1s,5r,8s,9s,11r,13r,14s,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

C20H27NO3 (329.1991)


   

(1s,3s,5r,8r,9s,10r,11r,14r,16s,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

(1s,3s,5r,8r,9s,10r,11r,14r,16s,17r,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

n-(1,4-dimethoxy-1,4-dioxobutan-2-yl)-9-methyldecanimidic acid

n-(1,4-dimethoxy-1,4-dioxobutan-2-yl)-9-methyldecanimidic acid

C17H31NO5 (329.2202)


   

(1r,9r,10r)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

(1r,9r,10r)-5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(1-methoxyethyl)-3-methylbutanoate

C16H27NO6 (329.1838)


   

(1s,5r,8r,9s,10s,11r,14s,17r,18r,19s)-10,19-dihydroxy-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-one

(1s,5r,8r,9s,10s,11r,14s,17r,18r,19s)-10,19-dihydroxy-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-one

C20H27NO3 (329.1991)


   

(1s,5s,8s,9s,11r,13r,14s,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

(1s,5s,8s,9s,11r,13r,14s,16s,17r,18r,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-8,13,19-triol

C20H27NO3 (329.1991)


   

5,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-4-ol

5,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-4-ol

C19H23NO4 (329.1627)


   

10,19-dihydroxy-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-one

10,19-dihydroxy-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-one

C20H27NO3 (329.1991)


   

21-methoxy-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-triene

21-methoxy-5,7,18-trioxa-14-azahexacyclo[12.8.0.0¹,¹⁷.0²,¹⁰.0⁴,⁸.0¹⁷,¹⁹]docosa-2,4(8),9-triene

C19H23NO4 (329.1627)


   

(2s,3s)-2'-hydroxy-3-[(3r)-2-hydroxy-2,6-dimethylhept-5-en-3-yl]spiro[oxirane-2,3'-quinolin]-4'-one

(2s,3s)-2'-hydroxy-3-[(3r)-2-hydroxy-2,6-dimethylhept-5-en-3-yl]spiro[oxirane-2,3'-quinolin]-4'-one

C19H23NO4 (329.1627)


   

(1s,5s,6s,8r,9s,11r,13r,14r,16s,17s,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,13,19-triol

(1s,5s,6s,8r,9s,11r,13r,14r,16s,17s,18s,19s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,13,19-triol

C20H27NO3 (329.1991)


   

(1r,13r,15s,18r)-5,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-4-ol

(1r,13r,15s,18r)-5,18-dimethoxy-14-oxa-11-azapentacyclo[9.8.0.0¹,¹⁵.0²,⁷.0¹³,¹⁵]nonadeca-2(7),3,5,16-tetraen-4-ol

C19H23NO4 (329.1627)


   

2-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-6-ol

2-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-1-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C19H23NO4 (329.1627)


   

n-[(2r)-1,4-dimethoxy-1,4-dioxobutan-2-yl]-9-methyldecanimidic acid

n-[(2r)-1,4-dimethoxy-1,4-dioxobutan-2-yl]-9-methyldecanimidic acid

C17H31NO5 (329.2202)


   

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

C20H27NO3 (329.1991)


   

7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

7,8,11-trimethoxy-1h,2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-12-one

C19H23NO4 (329.1627)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

C16H27NO6 (329.1838)


   

(1s,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

(1s,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C19H23NO4 (329.1627)


   

(1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

(1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-yl acetate

C19H23NO4 (329.1627)


   

(1s,5s,13s,16r,17s,18r,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,16,19-triol

(1s,5s,13s,16r,17s,18r,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,16,19-triol

C20H27NO3 (329.1991)


   

5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

C19H23NO4 (329.1627)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H27NO3 (329.1991)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,13,18-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,13,18-triol

C20H27NO3 (329.1991)


   

(1s,4s,12s,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

(1s,4s,12s,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7,9-triene-7,17-diol

C20H27NO3 (329.1991)


   

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-triol

5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-triol

C20H27NO3 (329.1991)


   

(4z)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropylidene)pyrrolidine-2,5-dione

(4z)-1-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-4-(2-methylpropylidene)pyrrolidine-2,5-dione

C19H23NO4 (329.1627)


   

(1s,9r,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

(1s,9r,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C19H23NO4 (329.1627)


   

(1r,2r,5r,7r,8r,9r,10s,13r,16s,17r)-7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

(1r,2r,5r,7r,8r,9r,10s,13r,16s,17r)-7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one

C20H27NO3 (329.1991)


   

15,16-dimethoxy-10-methyl-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

15,16-dimethoxy-10-methyl-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,13(17),14-pentaen-5-ol

C19H23NO4 (329.1627)


   

(9bs,11r)-5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

(9bs,11r)-5,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-ol

C19H23NO4 (329.1627)


   

1-[(4-hydroxyphenyl)methyl]-5,6-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

1-[(4-hydroxyphenyl)methyl]-5,6-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-7-ol

C19H23NO4 (329.1627)


   

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-ol

C19H23NO4 (329.1627)


   

(1r,9s,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

(1r,9s,10r)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraen-13-one

C19H23NO4 (329.1627)


   

(1s,17s)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

(1s,17s)-4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene

C20H27NO3 (329.1991)


   

(1s,4'r,6s)-6,10',11'-trimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

(1s,4'r,6s)-6,10',11'-trimethoxy-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,8'(12'),9'-tetraen-4-one

C19H23NO4 (329.1627)


   

(1s,2r,5s,8r,9s,11r,13r,14r,15r,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

(1s,2r,5s,8r,9s,11r,13r,14r,15r,16r,17r,18s)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,13,15-triol

C20H27NO3 (329.1991)


   

5-[(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)methyl]-2-methoxyphenol

5-[(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)methyl]-2-methoxyphenol

C19H23NO4 (329.1627)


   

(1r)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

(1r)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-6-ol

C19H23NO4 (329.1627)


   

(z)-cinnamoylcocaine

(z)-cinnamoylcocaine

C19H23NO4 (329.1627)


   

(1s,7as)-1-hydroxy-7-{[(2-hydroxy-2-isopropyl-3-methoxybutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7as)-1-hydroxy-7-{[(2-hydroxy-2-isopropyl-3-methoxybutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-4-ium-4-olate

C16H27NO6 (329.1838)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2,3-dihydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

C16H27NO6 (329.1838)


   

(9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

(9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-3-ium-3-olate

C19H23NO4 (329.1627)


   

5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

5-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-12-one

C19H23NO4 (329.1627)


   

methyl (1r,2r,3r,5s)-8-methyl-3-{[(2e)-3-phenylprop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octane-2-carboxylate

methyl (1r,2r,3r,5s)-8-methyl-3-{[(2e)-3-phenylprop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octane-2-carboxylate

C19H23NO4 (329.1627)


   

2'-hydroxy-3-(2-hydroxy-2,6-dimethylhept-5-en-3-yl)spiro[oxirane-2,3'-quinolin]-4'-one

2'-hydroxy-3-(2-hydroxy-2,6-dimethylhept-5-en-3-yl)spiro[oxirane-2,3'-quinolin]-4'-one

C19H23NO4 (329.1627)


   

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,8-dienimidic acid

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)nona-2,8-dienimidic acid

C20H27NO3 (329.1991)


   

8-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)oct-7-en-1-one

8-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)oct-7-en-1-one

C20H27NO3 (329.1991)